Detalhe da pesquisa
1.
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China.
BMC Cancer
; 23(1): 930, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37784037
2.
Wnt and BMP signaling pathways co-operatively induce the differentiation of multiple myeloma mesenchymal stem cells into osteoblasts by upregulating EMX2.
J Cell Biochem
; 120(4): 6515-6527, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30450775
3.
CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells.
Cancer Cell Int
; 18: 96, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30002603
4.
[Clinical Features and Prognostic Analysis of Newly Diagnosed Diffuse Large B-cell Lymphoma Combined with Hemophagocytic Syndrome].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 32(2): 466-469, 2024 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-38660853
5.
Global emergence of double and multi-carbapenemase producing organisms: epidemiology, clinical significance, and evolutionary benefits on antimicrobial resistance and virulence.
Microbiol Spectr
; : e0000824, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38860788
6.
[Effects of Different Nutritional Scoring Systems on Prognosis of Elderly Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 32(2): 499-504, 2024 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-38660858
7.
[Risk Factors and Prognosis of Cardiovascular Damage in Hypereosinophilia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(3): 810-815, 2023 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-37356944
8.
[Efficacy and Safety of Bendamustine in the Conditioning Regiment for Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(4): 1179-1183, 2023.
Artigo
em Zh
| MEDLINE | ID: mdl-37551495
9.
[Clinical Anslysis of TAFRO Syndrome].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(6): 1872-1877, 2023 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-38071075
10.
[Clinical Features and Prognosis of Patients with Castleman's Disease].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(1): 135-140, 2023 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-36765490
11.
[Coagulation Indexes and Their Prognostic Significance in Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(3): 791-796, 2021 Jun.
Artigo
em Zh
| MEDLINE | ID: mdl-34105474
12.
[Value of Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio in the Prognosis of Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(1): 122-130, 2021 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-33554808
13.
[Clinical Characteristics and Prognosis of Patients with Primary Bone Diffuse Large B-Cell Lymphoma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(5): 1517-1521, 2021 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-34627433
14.
[Analysis on Related Factors of Pulmonary Infection in Patients with Multiple Myeloma Treated with Bortezomib].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(1): 152-157, 2021 Feb.
Artigo
em Zh
| MEDLINE | ID: mdl-33554812
15.
[The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(2): 530-534, 2021 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-33812426
16.
Treatment and outcome patterns of patients with Waldenström's macroglobulinemia: a large, multicenter retrospective review in China.
Leuk Lymphoma
; 62(11): 2657-2664, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105439
17.
[Correlation of Body Mass Index, ABO Blood Group with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 28(4): 1261-1266, 2020 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-32798409
18.
[Analysis of Risk Factors of Herpes Zoster in Patients with Multiple Myeloma Treated with Bortezomib].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 28(6): 1972-1976, 2020 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-33283728
19.
[Significance of Neutrophil/Lymphocyte Ratio in the Prognosis of Patients with Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 27(2): 489-493, 2019 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-30998159